Our Partnerships

Coronis Greenberg Ltd. was established in May 2005 as a fully owned subsidiary of Coronis Partners Ltd. and serves as the General Partner in all Epione BioInvestment partnerships, and provides management services to SH.L.H.S, a limited partnership that has invested in BiondVax Ltd.
To date Coronis Greenberg Ltd. manages six partnerships and aggregates more than 120 private investors which have invested a more than $10M in seven Biomedical companies – BiondVax Ltd., Rosetta Genomics Ltd., Evogene Ltd., Sepal pharma Plc., Salio Inc. Modigene Inc. and Glycominds Ltd.